Laverock Therapeutics
Laverock secures funding for gene-control platform development
June 4, 2026Research and Development Laverock Therapeutics
Laverock Therapeutics has been awarded more than £2.2m in grant funding to support development of its gene-control platform and expand …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
